Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Kilgore

(1,733 posts)
Fri Jun 5, 2020, 09:00 AM Jun 2020

Authors Retract Studies That Found Risks of Antimalaria Drugs for Covid-19

https://www.wsj.com/articles/authors-retract-study-that-found-risks-of-using-antimalaria-drug-against-covid-19-11591299329

Two major studies casting doubt on the ability of antimalaria drugs to treat Covid-19 patients based on data from a little-known Chicago company, Surgisphere Corp., were retracted Thursday.

The Lancet first pulled a study published late last month that found antimalarials provided no benefit as a treatment for Covid-19 infections while increasing the risk of heart problems and death. The New England Journal of Medicine then retracted a separate article, published in early May, that examined the impact of cardiovascular and blood-pressure drugs in Covid-19 patients.

Both articles featured three of the same authors, Mandeep Mehra, Amit Patel and Sapan Desai, and were based on data supplied by Dr. Desai’s company, Surgisphere.

Surgisphere had said it collected the de-identified patient information from hospitals that was used in the studies. The Wall Street Journal contacted more than a dozen large U.S. hospitals, including some that treated high numbers of Covid-19 patients. None said they had an arrangement to share patient data with Surgisphere, and several said they had never heard of it.
5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Authors Retract Studies That Found Risks of Antimalaria Drugs for Covid-19 (Original Post) Kilgore Jun 2020 OP
Those weren't double blind studies. When those are conducted, we will see if there still_one Jun 2020 #1
I agree Kilgore Jun 2020 #2
+1 still_one Jun 2020 #3
Not. LisaL Jun 2020 #4
This study I was unaware of, and it looks like it was done correctly still_one Jun 2020 #5

still_one

(92,219 posts)
1. Those weren't double blind studies. When those are conducted, we will see if there
Fri Jun 5, 2020, 09:04 AM
Jun 2020

is any merit to it or not


LisaL

(44,973 posts)
4. Not.
Fri Jun 5, 2020, 09:25 PM
Jun 2020

Totally useless.
"The biggest clinical trials to test the efficacy of hydroxychloroquine as a COVID-19 treatment has been stopped by the United Kingdom as “no benefit was found”. The trial run by the University of Oxford has stopped enrolling patients with immediate effect saying “hydroxychloroquine does not benefit hospitalised COVID-19 patients” and “it did not reduce the risk of death.”"

https://www.cnbctv18.com/healthcare/uk-halts-trial-of-hydroxychloroquine-as-useless-for-coronavirus-patients-6082861.htm

Latest Discussions»General Discussion»Authors Retract Studies T...